The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2022 | Improving approaches to treatment and clinical trial design
Xavier Leleu, MD, MSc, PhD , Poitiers University Hospital, Poitiers, France, shares some insights into how approaches to clinical trials and treatment in multiple myeloma should be changed, drawing focus on the importance of novel immunotherapeutic agents. Prof. Leleu highlights the controversies surrounding this topic and shares some opinions on how treatment and clinical trial design may be improved. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
